Trial Profile
Pharmacodynamic and pharmacokinetic study of Ultra-rapid Lispro (URLi) by using insulin pump (CSII) versus humalog in patients with type 1 diabetes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Oct 2018
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
- 23 Jul 2018 New trial record
- 26 Jun 2018 Results presented at the 78th Annual Scientific Sessions of the American Diabetes Association